The PAX2 gene is mutated in patients with ocular colobomas, vesicoureteral reflux (VUR), and kidney anomalies (renalcoloboma syndrome, OMIM 120330). The three abnormalities which make up this syndrome also occur in isolation, but the causal genes are not known. PAX2 encodes a transcription factor of the paired box class of DNA binding proteins, important for the development of the urogenital tract, optic nerve and adjacent retina, inner ear, and CNS. In this paper we have investigated the prevalence ofPAX2 mutations in patients with ocular colobomas, microphthalmos, or retinal anomalies, either in isolation or with associated urogenital anomalies. Using PCR-SSCP, most or all exons of PAX2 were examined in blood DNA from 99 patients who have either ocular anomalies alone or a combination of ocular and urogenital conditions. PAX2 mutations were not detected in patients with ocular colobomas, either in isolation or with associated abnormalities, except in one patient with typical renal-coloboma syndrome. We conclude that PAX2 mutations are unlikely to be common in patients with ocular colobomas in isolation or in patients with ocular colobomas and associated anomalies, except for patients with typical renalcoloboma syndrome where PAX2 is known to be the aetiological cause. (JMed Genet 1998;35:806-8 12) 
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Keywords: PAX2; renal-coloboma syndrome; coloboma; vesicoureteric reflux Ocular colobomas (gaps or fissures in the structures of the eye) are a relatively common malformation which can occur either sporadically or as an autosomal dominantly inherited malformation involving the iris, retina, choroid, or optic nerve. ' The incidence of coloboma in the population is unknown. Colobomas may occur as isolated malformations or as part of a complex multisystem syndrome.' Typically, colobomas result from failure of fusion of the embryonic fissure of the optic cup anywhere along the line extending from the optic disc to the inferonasal border of the pupillary margin.
For the purposes of the present paper we shall define the term coloboma to include lesions affecting the optic nerve (ranging from optic disc dysplasia to optic nerve aplasia), retina, choroid, and iris, but not the eyelids. Orbital cysts and microphthalmia are also considered to be part of the spectrum of colobomatous defects resulting from failure of fusion of the embryonic fissure in the optic cup. Rarely, colobomas are reported in association with other developmental anomalies. For example, renal-coloboma syndrome (MIM 120330 glycerol, and electrophoresis at 25°C or at 4°C.
The PCR product from the promoter region was digested with SmaI restriction enzyme (Promega) to yield three fragments of 325, 233, and 232 bp, which were resolved on SSCP gels.
SUBCLONING AND DNA SEQUENCING PCR products were directly sequenced using a32P-dCTP and a cycle sequencing kit (GIBCO-BRL). For subcloning of exon 2 PCR products, mutant and normal alleles of PAX2 were amplified using Pwo DNA polymerase (Boehringer Mannheim), and subcloned into EcoRV digested pBluescript II (Stratagene). Positive clones were identified by blue/white selection, and plasmid DNA was isolated using Wizard mini-preps kits (Promega). Sequencing reactions were carried out on plasmid DNA using 35S-dATP and a double stranded sequencing kit (USB).
PAX2 ALLELE DELETION STUDIES
PAX2 mutations could include a deletion of either a part or the whole PAX2 gene from one allele. Such deletions may not necessarily be detected by PCR-SSCP. To investigate whether deletions of the whole PAX2 gene had occurred, heterozygosity of the PAX2 gene was analysed in each patient by amplification of a (CA), dinucleotide repeat within intron 9 as previously described.30 Amplification of both alleles was evidence of heterozygosity.
Results

PAX2 MUTATIONAL STUDIES
The results of PCR-SSCP analysis ofthe PAX2 gene in 99 patients are summarised in tables 1 and 2, along with a summary of the PAX2 mutations which have previously been identified in 11 patients. One patient in this study (patient 985) was found to have an abnormal SSCP pattern in exon 2. No variations in PCR-SSCP patterns were observed in unaffected parental samples of patient 985 (fig 1A) or in 98 other subjects analysed for each exon of PAX2. To identify the PAX2 mutation in patient 985, exon 2 PCR products of patient 985 and his parents were subcloned and sequenced. Sequencing of independently derived mutant alleles from patient 985 identified a deletion of a thymidine nucleotide at position 611 in approximately 50% of clones (fig iB) . Normal alleles were found in the remainder of the clones from patient 985. The observed nucleotide deletion causes a frameshift in exon 2, and would be predicted to terminate the protein within exon 6 encoded sequences ( fig  2) . The predicted protein would be unable to bind DNA as it would lack much of the paired box DNA binding domain. This mutation would effectively result in haploinsufficiency of PAX2 because the predicted protein from the mutant allele would be non-functional. Fig 2  depicts the location of the mutation in the PAX2 protein and the frameshifted protein which is predicted to result from the mutation, and compares the effect of this mutation to other previously described mutations in PAX2.
CLINICAL REPORT OF PATIENT 985
Patient 985 is the second child born to non-consanguinous Dutch parents. He was We have previously reported that PAX2 mutations are absent in patients with isolated familial vesicoureteric reflux." " These findings suggest that PAX2 mutations may not be found in patients with ureteric anomalies in isolation. However, it remains to be determined whether PAX2 mutations will be associated with isolated renal abnormalities. PAX2 mutations are associated with renal hypoplasia, tubular atrophy, glomerulosclerosis, progressive renal failure, and vesicoureteric reflux ( That we did not detect PAX2 mutations in 98 patients who had either ocular abnormalities in isolation or eye defects with associated abnormalities suggests that PAX2 mutations do not cause colobomas in isolation, microphthalmia or retinal anomalies, or syndromes of coloboma, renal anomalies, and atypical associated features. In agreement with these results a family with dominant inheritance of optic pits was analysed for PAX2 mutations by SSCP in exons 1-10 of PAX2 and was not found to have PAX2 sequence variants.36 Included among the patients analysed in this study were two patients with a subtype of Joubert syndrome, referred to as Dekaban syndrome9 (chorioretinal coloboma with cerebellar vermis aplasia and polycystic kidneys) (patients 626 and 627), and also two patients with Arima syndrome37 (blindness, cerebellar vermis agenesis, polycystic kidneys, hepatic fibrosis) (patients 630 and 633). Several other syndromes, for example acro-renal-ocular syndrome,"' branchio-oculo-facial syndrome,'3 and cat eye syndrome,"4 may include optic nerve colobomas as part of the phenotype, but we have not examined such patients for PAX2 mutations.
In this study three families had a syndrome that was considered to be identical to renalcoloboma syndrome (patients 651, 813, 814, 816, 906, and 907), yet PAX2 mutations were not identified in these patients. One explanation for the lack of PAX2 mutations is that there is a low level of PCR-SSCP sensitivity in our screening procedure, and that certain types of mutations are not being detected.38 However, our experience with the PCR-SSCP method has shown that it is sufficiently sensitive (85-100% detection rate) to identify polymorphisms in DNA sequences with a GC content ranging from 55 to 68% (HEC, unpublished data). 
